AGM/EGMApr 30, 2026, 05:02 PM
SUPN Annual Meeting on June 18, 2026; Key Proposals
AI Summary
Supernus Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 18, 2026. Stockholders will vote on the election of two directors, the non-binding approval of executive compensation, the ratification of KPMG LLP as independent auditor, and a proposal to increase shares available under the 2021 Equity Incentive Plan. The record date for voting was April 29, 2026.
Key Highlights
- Stockholders to elect two directors for a three-year term.
- Non-binding vote on named executive officer compensation.
- Ratification of KPMG LLP as independent auditor for fiscal year 2026.
- Proposal to amend the 2021 Equity Incentive Plan to increase available shares.
- Annual Meeting to be held virtually on June 18, 2026, at 10:00 A.M. EDT.
- Record Date for voting is April 29, 2026, with 58,039,721 shares outstanding.
Price Impact
More from SUPN